Target Validation in Drug Discovery

0 avg rating
( 0 ratings by Goodreads )
 
9780123693938: Target Validation in Drug Discovery

This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book.

"synopsis" may belong to another edition of this title.

From the Back Cover:

The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive sequencing effort. A major concern for researchers in the biotechnology and pharmaceutical industries is how to choose the most likely targets for drug discovery and how to validate them.

Target Validation in Drug Discovery describes the background for the choice of target for several successful biological drugs (protein therapeutics). It offers excellent analyses of the underlying biology, the establishment of relative assays, and the translation to clinical trials of these drugs. Professionals in biotechnology and pharmaceutical drug discovery, clinical development, students, and academics in related areas of study will find this a unique reference for years to come.

· Includes detailed descriptions of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics
· Takes a look at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin
· Additional targets known as "second generation" drugs are covered and present new possible small molecule therapeutics
· Details approaches to design of orally active drugs against new disease mechanisms
· Contains contemporary technologies in drug discovery and case histories of successful drugs

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Published by Academic Press (2006)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover First Edition Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Academic Press, 2006. Hardcover. Book Condition: New. book. Bookseller Inventory # M0123693934

More Information About This Seller | Ask Bookseller a Question

Buy New
20.37
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

2.

Published by Academic Press (2017)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover Quantity Available: 2
Print on Demand
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Academic Press, 2017. Hardcover. Book Condition: New. Never used! This item is printed on demand. Bookseller Inventory # P110123693934

More Information About This Seller | Ask Bookseller a Question

Buy New
38.11
Convert Currency

Add to Basket

Shipping: 1.51
Within U.S.A.
Destination, Rates & Speeds

3.

Brian W. Metcalf and Susan Dillon
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Quantity Available: 1
Seller:
Bookshub
(Karol Bagh, India)
Rating
[?]

Book Description Book Condition: New. New. US edition. Perfect condition. Customer satisfaction our priority. Bookseller Inventory # ABE-FEB-16417

More Information About This Seller | Ask Bookseller a Question

Buy New
44.14
Convert Currency

Add to Basket

Shipping: FREE
From India to U.S.A.
Destination, Rates & Speeds

4.

Brian W. Metcalf and Susan Dillon
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Quantity Available: 1
Seller:
EBOOKSTORE2010
(New Delhi, ND, India)
Rating
[?]

Book Description Book Condition: Brand New. New. US edition. Customer Satisfaction guaranteed!!. Bookseller Inventory # SHUB16417

More Information About This Seller | Ask Bookseller a Question

Buy New
44.18
Convert Currency

Add to Basket

Shipping: FREE
From India to U.S.A.
Destination, Rates & Speeds

5.

Brian W. Metcalf and Susan Dillon
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Quantity Available: 1
Seller:
Basi6 International
(Irving, TX, U.S.A.)
Rating
[?]

Book Description Book Condition: Brand New. New, US edition. Excellent Customer Service. Bookseller Inventory # ABEUSA-16417

More Information About This Seller | Ask Bookseller a Question

Buy New
46.43
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds
International Edition
International Edition

6.

Metcalf, Brian W.; Dillon, Susan
Published by Elsevier Science and Technology (2006)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover Quantity Available: 1
International Edition
Seller:
Secret Knowledge Books
(Tualatin, OR, U.S.A.)
Rating
[?]

Book Description Elsevier Science and Technology, 2006. Hard Cover. Book Condition: Brand New. First Edition. new, international edition, oversize hardcover, XII, 279 pp, 26.5 X 19 cm, same content 4to - over 9? - 12" tall. Bookseller Inventory # 001507

More Information About This Seller | Ask Bookseller a Question

Buy New
46.85
Convert Currency

Add to Basket

Shipping: 2.99
Within U.S.A.
Destination, Rates & Speeds

7.

Published by Elsevier Science Publishing Co Inc, United States (2006)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2006. Hardback. Book Condition: New. New.. Language: English . Brand New Book. This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as second generation drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book. Bookseller Inventory # AA59780123693938

More Information About This Seller | Ask Bookseller a Question

Buy New
53.02
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Published by Elsevier Science Publishing Co Inc, United States (2006)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover Quantity Available: 1
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2006. Hardback. Book Condition: New. New.. Language: English . Brand New Book. This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as second generation drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book. Bookseller Inventory # AA59780123693938

More Information About This Seller | Ask Bookseller a Question

Buy New
55.81
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Brian W. Metcalf (Editor), Susan Dillon (Editor)
Published by Academic Press (2006)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Academic Press, 2006. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX0123693934

More Information About This Seller | Ask Bookseller a Question

Buy New
59.39
Convert Currency

Add to Basket

Shipping: 3.02
Within U.S.A.
Destination, Rates & Speeds

10.

Dillon
Published by Academic Press (2016)
ISBN 10: 0123693934 ISBN 13: 9780123693938
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Academic Press, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9780123693938_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
69.99
Convert Currency

Add to Basket

Shipping: 3.87
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book